Neurocrine Biosciences announced data analysis from two phase 3 trials evaluating opicapone added to levodopa for Parkinson’s disease was presented […]
Israeli researchers from Tel Aviv University found that when healthy older adults turn to sit, about 80% of them complete […]
A prominent couple (Rodger and Paula Riney) have made a $15 million gift to Washington University of Medicine, St. Louis. […]
Researchers from Chinese University Hong Kong (CUHK) report that people with first-degree relatives suffering from rapid eye movement sleep behavioral […]
France-based Servier and Oncodesign have agreed to partner on the development of LRRK2 kinase inhibitors in Parkinson’s disease. Servier to […]
The Michael J. Fox Foundation and Silverstein Foundation for Parkinson’s with GBA teamed up to provide funding to leverage resources […]
Parkinson’s UK is funding a pioneering clinical trials program. It centers on investigational treatment directly to the brain. The sponsor’s […]
Dallas News reports that UT Southwestern has hired well-known neurologist Dr. William T. Dauer. He will lead the Peter O’Donnell […]
As reported by UNSW Sydney Newsroom, the Australian Parkinson’s Mission, an innovative program combining clinical trials with genomics research for […]
As reported in Neurology Today’s by Olga Rukovets, the likelihood of developing a Parkinson’s disease-related movement disorder was two to three […]
